SARAH D CULBERTSON — History
CCN 141333 | 3-year financial timeline | COVID resilience: 45/100
🛡️ Public data only — no PHI permitted on this instance.
$26M
Latest Revenue (FY2022)
+7.1%
Revenue CAGR (3yr)
-3.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $23M | $23M | $26M | +14.8% | +7.1% |
| Operating Expenses | $21M | $22M | $27M | +22.3% | +11.8% |
| Operating Margin | 5.1% | 3.0% | -3.3% | -212.5% | +0.0% |
| Net Income | $1M | $1M | $-1M | -229.1% | +0.0% |
| Licensed Beds | 22 | 22 | 22 | +0.0% | +0.0% |
| Total Patient Days | 591 | 522 | 462 | -11.5% | -11.6% |
| Medicare Day % | 69% | 58% | 55% | -4.2% | -10.1% |
| Medicaid Day % | 4% | 11% | 5% | -50.7% | +13.1% |
COVID Impact & Recovery
Resilience Score: 45/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +14.8% ($23M → $26M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.1%
This Hospital
+7.6%
State Avg
Latest Margin
-3.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $28M | -7.6% |
| FY2024 (proj) | $29M | -11.8% |
| FY2025 (proj) | $31M | -16.0% |